INSULINE NovoRapid flac 10 ml

7680550450024 CH-55045 A10AB05 07.06.1.
INSULINE NovoRapid flac 10 ml
INSULINE NovoRapid flac 10 ml
1 / 2
google

Details

Product number
5504501
CPT
-
Packaging group
10
Unit
ml
Composition
insulinum aspartum 100 U. Corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg.

Articles (1)

Insulin NovoNordisk NovoRapid, Injektionslösung
Injektionslösung
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/02/2023
Patient information leaflet
Français
15/02/2023
Patient information leaflet
Italien
15/02/2023
Professional SmPC
Allemand
24/06/2021
Professional SmPC
Français
24/06/2021
Professional SmPC
Italien
24/06/2021

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 U Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.9 MG Substance HBESI

Reimbursement information

Public price
CHF 37.90
Specialties list
Yes
Generic
No
SL addition date: 01/01/2000

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
55045
Drug name
Insulin NovoNordisk NovoRapid, Injektionslösung
Galenic form
LSIMD
ATC Code
A10AB05
Authorization status
Z
Dispensation category
B
First authorization
15/06/1999
Authorization expiration date
31/12/9999
IT number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Packaging details

Description (FR)
INSULINE NovoRapid flac 10 ml
Description (DE)
INSULIN NovoRapid Durchstf 10 ml
Market launch
15/06/1999
Narcotic (BTM)
No